Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.40
+0.06 (0.17%)
At close: Nov 17, 2025, 4:00 PM EST
34.40
0.00 (0.00%)
After-hours: Nov 17, 2025, 4:15 PM EST
HRTS Holdings Information
HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 10.51%, Roche Holding AG at 4.38%, UnitedHealth Group at 4.31%, AstraZeneca at 4.29%, and Abbott Laboratories at 3.93%.
Total Holdings
25
Top 10 Percentage
44.55%
Asset Class
Equity
ETF Category
Health
Assets
50.59M
PE Ratio
21.19
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.51% |
| 2 | RHHBY | Roche Holding AG | 4.38% |
| 3 | UNH | UnitedHealth Group Incorporated | 4.31% |
| 4 | LON: AZN | AstraZeneca PLC | 4.29% |
| 5 | ABT | Abbott Laboratories | 3.93% |
| 6 | GILD | Gilead Sciences, Inc. | 3.82% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.65% |
| 8 | BSX | Boston Scientific Corporation | 3.53% |
| 9 | ABBV | AbbVie Inc. | 3.10% |
| 10 | JNJ | Johnson & Johnson | 3.03% |
| 11 | SWX: NOVN | Novartis AG | 2.98% |
| 12 | MDT | Medtronic plc | 2.93% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.70% |
| 14 | DHR | Danaher Corporation | 2.66% |
| 15 | CPH: NOVO.B | Novo Nordisk A/S | 2.53% |
| 16 | MRK | Merck & Co., Inc. | 2.38% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.22% |
| 18 | AMGN | Amgen Inc. | 2.15% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 1.98% |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.96% |
| 21 | MCK | McKesson Corporation | 1.95% |
| 22 | CYTK | Cytokinetics, Incorporated | 1.93% |
| 23 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.81% |
| 24 | RVMD | Revolution Medicines, Inc. | 1.78% |
| 25 | BMY | Bristol-Myers Squibb Company | 1.77% |
Showing 25 of 45 holdings
Get a Stock Analysis Pro account to see the full list of holdings and get unlimited access to all data and
tools.
As of Nov 13, 2025